TY - JOUR
T1 - Regulation of nerve growth factor mRNA in the hippocampal formation
T2 - Effects of N-methyl-D-aspartate receptor activation
AU - Gwag, B. J.
AU - Sessler, F. M.
AU - Waterhouse, B. D.
AU - Springer, J. E.
PY - 1993/6
Y1 - 1993/6
N2 - In the hippocampal formation, nerve growth factor (NGF) is produced in granule cells of the dentate gyrus and a few pyramidal cells of Ammon's horn. Both neuronal populations express N-methyl-D-aspartate (NMDA) receptors and receive putative glutamatergic afferents originating in the entorhinal cortex and projecting via the perforant path. We report in this study that intrahippocampal or intraventricular injections of NMDA increase NGF mRNA levels in dentate gyrus granule cells as determined using in situ hybridization histochemistry and a solution hybridization assay. NGF mRNA induction is detected within 2 h following NMDA treatment and returns to control levels within 24 h. This NMDA effect is dose-dependent and blocked by pretreatment with 2-amino-5-phosphonopentanoic acid, a competitive NMDA antagonist. Finally, the induction of NGF mRNA is observed in the absence of detectable neurotoxicity or seizure activity. We postulate that normal physiological events associated with the activation of hippocampal NMDA receptors may regulate mRNA expression of this neurotrophic factor.
AB - In the hippocampal formation, nerve growth factor (NGF) is produced in granule cells of the dentate gyrus and a few pyramidal cells of Ammon's horn. Both neuronal populations express N-methyl-D-aspartate (NMDA) receptors and receive putative glutamatergic afferents originating in the entorhinal cortex and projecting via the perforant path. We report in this study that intrahippocampal or intraventricular injections of NMDA increase NGF mRNA levels in dentate gyrus granule cells as determined using in situ hybridization histochemistry and a solution hybridization assay. NGF mRNA induction is detected within 2 h following NMDA treatment and returns to control levels within 24 h. This NMDA effect is dose-dependent and blocked by pretreatment with 2-amino-5-phosphonopentanoic acid, a competitive NMDA antagonist. Finally, the induction of NGF mRNA is observed in the absence of detectable neurotoxicity or seizure activity. We postulate that normal physiological events associated with the activation of hippocampal NMDA receptors may regulate mRNA expression of this neurotrophic factor.
UR - http://www.scopus.com/inward/record.url?scp=0027320148&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0027320148&partnerID=8YFLogxK
U2 - 10.1006/exnr.1993.1083
DO - 10.1006/exnr.1993.1083
M3 - Article
C2 - 8339768
AN - SCOPUS:0027320148
SN - 0014-4886
VL - 121
SP - 160
EP - 171
JO - Experimental Neurology
JF - Experimental Neurology
IS - 2
ER -